{"id":"https://openalex.org/W4403136288","doi":"https://doi.org/10.1038/s42256-024-00911-w","title":"A call for an industry-led initiative to critically assess machine learning for real-world drug discovery","display_name":"A call for an industry-led initiative to critically assess machine learning for real-world drug discovery","publication_year":2024,"publication_date":"2024-10-04","ids":{"openalex":"https://openalex.org/W4403136288","doi":"https://doi.org/10.1038/s42256-024-00911-w"},"language":"en","primary_location":{"id":"doi:10.1038/s42256-024-00911-w","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s42256-024-00911-w","pdf_url":null,"source":{"id":"https://openalex.org/S2912241403","display_name":"Nature Machine Intelligence","issn_l":"2522-5839","issn":["2522-5839"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Machine Intelligence","raw_type":"journal-article"},"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5092090018","display_name":"Cas Wognum","orcid":"https://orcid.org/0009-0006-2742-4817"},"institutions":[{"id":"https://openalex.org/I4210134158","display_name":"Centre Hospitalier de Valence","ror":"https://ror.org/02qykes20","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210134158"]},{"id":"https://openalex.org/I4210159509","display_name":"Recursion (United States)","ror":"https://ror.org/05czpzc54","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159509"]}],"countries":["FR","US"],"is_corresponding":true,"raw_author_name":"Cas Wognum","raw_affiliation_strings":["Recursion, Salt Lake City, UT, USA","Valence Labs, Montr\u00e9al, Quebec, Canada"],"affiliations":[{"raw_affiliation_string":"Recursion, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I4210159509"]},{"raw_affiliation_string":"Valence Labs, Montr\u00e9al, Quebec, Canada","institution_ids":["https://openalex.org/I4210134158"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087842723","display_name":"Jeremy R. Ash","orcid":"https://orcid.org/0000-0002-8041-8524"},"institutions":[{"id":"https://openalex.org/I1330063522","display_name":"Johnson & Johnson (United States)","ror":"https://ror.org/03qd7mz70","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeremy R. Ash","raw_affiliation_strings":["Johnson & Johnson Innovative Medicine, Spring House, PA, USA"],"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Innovative Medicine, Spring House, PA, USA","institution_ids":["https://openalex.org/I1330063522"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056535696","display_name":"Matteo Aldeghi","orcid":"https://orcid.org/0000-0003-0019-8806"},"institutions":[{"id":"https://openalex.org/I150569930","display_name":"Bayer (United States)","ror":"https://ror.org/034ffbg36","country_code":"US","type":"company","lineage":["https://openalex.org/I150569930","https://openalex.org/I67348948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matteo Aldeghi","raw_affiliation_strings":["Bayer Research and Innovation Center, Cambridge, MA, USA"],"affiliations":[{"raw_affiliation_string":"Bayer Research and Innovation Center, Cambridge, MA, USA","institution_ids":["https://openalex.org/I150569930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038390721","display_name":"Raquel Rodr\u00edguez-P\u00e9rez","orcid":"https://orcid.org/0000-0002-2992-3402"},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Raquel Rodr\u00edguez-P\u00e9rez","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland"],"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028328003","display_name":"Cheng Fang","orcid":"https://orcid.org/0000-0002-9767-2043"},"institutions":[{"id":"https://openalex.org/I4210100156","display_name":"Blueprint Medicines (United States)","ror":"https://ror.org/0142eak56","country_code":"US","type":"company","lineage":["https://openalex.org/I4210100156"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cheng Fang","raw_affiliation_strings":["Blueprint Medicines, Cambridge, MA, USA"],"affiliations":[{"raw_affiliation_string":"Blueprint Medicines, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210100156"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083026456","display_name":"Alan C. Cheng","orcid":"https://orcid.org/0000-0003-3645-172X"},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan C. Cheng","raw_affiliation_strings":["Merck & Co. Inc., South San Francisco, CA, USA"],"affiliations":[{"raw_affiliation_string":"Merck & Co. Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101173421","display_name":"Daniel Price","orcid":null},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel J. Price","raw_affiliation_strings":["Nimbus Therapeutics, Boston, MA, USA"],"affiliations":[{"raw_affiliation_string":"Nimbus Therapeutics, Boston, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044662284","display_name":"Djork-Arn\u00e9 Clevert","orcid":"https://orcid.org/0000-0003-4191-2156"},"institutions":[{"id":"https://openalex.org/I4210100293","display_name":"Pfizer (Germany)","ror":"https://ror.org/00m8w3m39","country_code":"DE","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210100293"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Djork-Arn\u00e9 Clevert","raw_affiliation_strings":["Pfizer Research and Development, Berlin, Germany"],"affiliations":[{"raw_affiliation_string":"Pfizer Research and Development, Berlin, Germany","institution_ids":["https://openalex.org/I4210100293"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076975589","display_name":"Ola Engkvist","orcid":"https://orcid.org/0000-0003-4970-6461"},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]},{"id":"https://openalex.org/I66862912","display_name":"Chalmers University of Technology","ror":"https://ror.org/040wg7k59","country_code":"SE","type":"education","lineage":["https://openalex.org/I66862912"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ola Engkvist","raw_affiliation_strings":["Department of Computer Science and Engineering, Chalmers University of Technology, Gothenburg, Sweden","Molecular AI, Discovery Sciences AstraZeneca R&D, Gothenburg, M\u00f6lndal, Sweden"],"affiliations":[{"raw_affiliation_string":"Department of Computer Science and Engineering, Chalmers University of Technology, Gothenburg, Sweden","institution_ids":["https://openalex.org/I66862912"]},{"raw_affiliation_string":"Molecular AI, Discovery Sciences AstraZeneca R&D, Gothenburg, M\u00f6lndal, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077218712","display_name":"W. Patrick Walters","orcid":"https://orcid.org/0000-0003-2860-7958"},"institutions":[{"id":"https://openalex.org/I4210116569","display_name":"Relay Therapeutics (United States)","ror":"https://ror.org/02bkgy413","country_code":"US","type":"company","lineage":["https://openalex.org/I4210116569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W. Patrick Walters","raw_affiliation_strings":["Relay Therapeutics, Cambridge, MA, USA"],"affiliations":[{"raw_affiliation_string":"Relay Therapeutics, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4210116569"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5092090018"],"corresponding_institution_ids":["https://openalex.org/I4210134158","https://openalex.org/I4210159509"],"apc_list":{"value":9750,"currency":"EUR","value_usd":11690},"apc_paid":null,"fwci":7.9398,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.97993842,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":90,"max":100},"biblio":{"volume":"6","issue":"10","first_page":"1120","last_page":"1121"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9994000196456909,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9994000196456909,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11948","display_name":"Machine Learning in Materials Science","score":0.9842000007629395,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13937","display_name":"Genetics, Bioinformatics, and Biomedical Research","score":0.9735000133514404,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-discovery","display_name":"Drug discovery","score":0.5908102989196777},{"id":"https://openalex.org/keywords/critically-ill","display_name":"Critically ill","score":0.5545305013656616},{"id":"https://openalex.org/keywords/business","display_name":"Business","score":0.46472933888435364},{"id":"https://openalex.org/keywords/medicine","display_name":"Medicine","score":0.41364622116088867},{"id":"https://openalex.org/keywords/drug","display_name":"Drug","score":0.4127689301967621},{"id":"https://openalex.org/keywords/intensive-care-medicine","display_name":"Intensive care medicine","score":0.3649497330188751},{"id":"https://openalex.org/keywords/computer-science","display_name":"Computer science","score":0.3549215793609619},{"id":"https://openalex.org/keywords/pharmacology","display_name":"Pharmacology","score":0.21085035800933838},{"id":"https://openalex.org/keywords/bioinformatics","display_name":"Bioinformatics","score":0.13623178005218506},{"id":"https://openalex.org/keywords/biology","display_name":"Biology","score":0.09014913439750671}],"concepts":[{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.5908102989196777},{"id":"https://openalex.org/C2991859549","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Critically ill","level":2,"score":0.5545305013656616},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.46472933888435364},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41364622116088867},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4127689301967621},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3649497330188751},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3549215793609619},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.21085035800933838},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.13623178005218506},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.09014913439750671}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1038/s42256-024-00911-w","is_oa":false,"landing_page_url":"https://doi.org/10.1038/s42256-024-00911-w","pdf_url":null,"source":{"id":"https://openalex.org/S2912241403","display_name":"Nature Machine Intelligence","issn_l":"2522-5839","issn":["2522-5839"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Machine Intelligence","raw_type":"journal-article"},{"id":"pmh:oai:oak.novartis.com:55234","is_oa":false,"landing_page_url":null,"pdf_url":null,"source":{"id":"https://openalex.org/S4306400709","display_name":"The Novartis Repository (Novartis)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I1283582996","host_organization_name":"Novartis (Switzerland)","host_organization_lineage":["https://openalex.org/I1283582996"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:oai:research.chalmers.se:543224","is_oa":false,"landing_page_url":"https://research.chalmers.se/en/publication/543224","pdf_url":null,"source":{"id":"https://openalex.org/S4306402469","display_name":"Chalmers Research (Chalmers University of Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"host_organization":"https://openalex.org/I66862912","host_organization_name":"Chalmers University of Technology","host_organization_lineage":["https://openalex.org/I66862912"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":""}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Partnerships for the goals","score":0.5,"id":"https://metadata.un.org/sdg/17"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W2594183968","https://openalex.org/W3177828909","https://openalex.org/W4296551289","https://openalex.org/W4385576721","https://openalex.org/W4388302761","https://openalex.org/W4388455891","https://openalex.org/W4391849759","https://openalex.org/W4392093325"],"related_works":["https://openalex.org/W4391375266","https://openalex.org/W2979685266","https://openalex.org/W4211157171","https://openalex.org/W2207493841","https://openalex.org/W2092069826","https://openalex.org/W2888412288","https://openalex.org/W4248977994","https://openalex.org/W2087141122","https://openalex.org/W2382071302","https://openalex.org/W3011206692"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":14},{"year":2024,"cited_by_count":1}],"updated_date":"2026-04-01T17:29:45.350535","created_date":"2024-10-05T00:00:00"}